We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

39 hedge funds and large institutions have $82.4M invested in CRH Medical Corporation in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less capital invested

Capital invested by funds: $94.4M → $82.4M (-$12M)

17% less funds holding

Funds holding: 4739 (-8)

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

89% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 9

Holders
39
Holders Change
-8
Holders Change %
-17.02%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
10
Reduced
19
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$16.6M -$772K -250,000 -4%
BGC
2
Beutel, Goodman & Co
Ontario, Canada
$12.5M -$1.24M -402,140 -8%
SCM
3
Stadium Capital Management
Connecticut
$9.73M +$4.56M +1,476,877 +68%
Morgan Stanley
4
Morgan Stanley
New York
$7.39M -$1.91M -619,186 -18%
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$5.65M -$199K -64,623 -3%
Stifel Financial
6
Stifel Financial
Missouri
$5.63M
PRCP
7
Pacific Ridge Capital Partners
Oregon
$5.52M +$732K +237,175 +13%
Canada Pension Plan Investment Board
8
Canada Pension Plan Investment Board
Ontario, Canada
$3.96M +$2.02M +654,600 +78%
JP Morgan Chase
9
JP Morgan Chase
New York
$3.21M -$340K -110,100 -8%
Deutsche Bank
10
Deutsche Bank
Germany
$3.06M +$87.5K +28,358 +3%
Goldman Sachs
11
Goldman Sachs
New York
$2.56M +$1.89M +611,281 +174%
Renaissance Technologies
12
Renaissance Technologies
New York
$1.72M +$121K +39,358 +6%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$858K +$1.24K +400 +0.1%
PP
14
Palladium Partners
Virginia
$553K
SCP
15
Seizert Capital Partners
Michigan
$454K
Two Sigma Advisers
16
Two Sigma Advisers
New York
$410K -$204K -66,200 -30%
RA
17
Royce & Associates
New York
$351K
WCM
18
Wedge Capital Management
North Carolina
$316K +$75.1K +24,347 +26%
Two Sigma Investments
19
Two Sigma Investments
New York
$288K -$404K -131,000 -55%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$260K -$419K -135,900 -58%
TD Asset Management
21
TD Asset Management
Ontario, Canada
$258K -$18.6K -6,012 -6%
BCIM
22
British Columbia Investment Management
British Columbia, Canada
$176K -$203K -65,821 -50%
QI
23
QS Investors
New York
$160K +$185K +60,000 New
SIM
24
Spark Investment Management
New York
$153K -$352K -114,000 -66%
CIBC World Market
25
CIBC World Market
Ontario, Canada
$136K -$459K -148,567 -74%

CRHM Hedge Fund Activity: Q1 2019 in Review

39 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q1 2019, worth a combined $82.4M — down 13% from $94.4M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CRHM and 1 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 10 added.

The largest buyer was Stadium Capital Management, adding an estimated $4.56M. The largest seller was Morgan Stanley, cutting an estimated $1.91M.

  • 39 institutional investors held CRH Medical Corporation (CRHM) as of Q1 2019, down from 47 in Q4 2018.
  • Funds reported $82.4M of CRH Medical Corporation stock for Q1 2019, down 13% quarter-over-quarter.
  • 1 fund opened new CRH Medical Corporation positions in Q1 2019 and 9 closed out, a net change of -8 holders.
  • The largest CRH Medical Corporation buyer in Q1 2019 was Stadium Capital Management, an estimated $4.56M added.
  • The largest CRH Medical Corporation seller in Q1 2019 was Morgan Stanley, an estimated $1.91M sold.

Based on aggregated 13F filings for Q1 2019.